was read the article
array:21 [ "pii" => "X2013251412000769" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2012.Jan.11339" "estado" => "S300" "fechaPublicacion" => "2012-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2012;32:253" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4994 "formatos" => array:3 [ "EPUB" => 312 "HTML" => 4033 "PDF" => 649 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "X0211699512000761" "issn" => "02116995" "doi" => "10.3265/Nefrologia.pre2012.Jan.11339" "estado" => "S300" "fechaPublicacion" => "2012-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2012;32:253" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 7731 "formatos" => array:3 [ "EPUB" => 289 "HTML" => 6815 "PDF" => 627 ] ] "es" => array:9 [ "idiomaDefecto" => true "titulo" => "Utilización de las ecuaciones de estimación del filtrado glomerular para el ajuste de dosis de fármacos" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "253" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Use of estimated glomerular filtration formulas for dose adjustment" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Rosario Montañés-Bermúdez, Sílvia Gràcia-Garcia" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Rosario" "apellidos" => "Montañés-Bermúdez" ] 1 => array:2 [ "nombre" => "Sílvia" "apellidos" => "Gràcia-Garcia" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251412000769" "doi" => "10.3265/Nefrologia.pre2012.Jan.11339" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412000769?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512000761?idApp=UINPBA000064" "url" => "/02116995/0000003200000002/v0_201502091353/X0211699512000761/v0_201502091354/es/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "X2013251412000750" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2011.Dec.11218" "estado" => "S300" "fechaPublicacion" => "2012-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2012;32:255-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 6470 "formatos" => array:3 [ "EPUB" => 307 "HTML" => 5561 "PDF" => 602 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Endogenous endophthalmitis as a complication of sepsis related to a tunnelled haemodialysis catheter" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "255" "paginaFinal" => "256" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Endoftalmitis endógena como complicación de sepsis con relación a catéter tunelizado para hemodiálisis" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11218_19157_29351_en_f1_9.11218.jpg" "Alto" => 519 "Ancho" => 657 "Tamanyo" => 127864 ] ] "descripcion" => array:1 [ "en" => "Ocular ultrasound" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Mara L. Cabana-Carcasi, Vanesa Becerra-Mosquera, Lourdes González-Tabarés, Daniel Novoa-García" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Mara L." "apellidos" => "Cabana-Carcasi" ] 1 => array:2 [ "nombre" => "Vanesa" "apellidos" => "Becerra-Mosquera" ] 2 => array:2 [ "nombre" => "Lourdes" "apellidos" => "González-Tabarés" ] 3 => array:2 [ "nombre" => "Daniel" "apellidos" => "Novoa-García" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699512000753" "doi" => "10.3265/Nefrologia.pre2011.Dec.11218" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512000753?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412000750?idApp=UINPBA000064" "url" => "/20132514/0000003200000002/v0_201502091616/X2013251412000750/v0_201502091617/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "X2013251412000777" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2012.Jan.11343" "estado" => "S300" "fechaPublicacion" => "2012-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2012;32:253" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3871 "formatos" => array:3 [ "EPUB" => 329 "HTML" => 2924 "PDF" => 618 ] ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Salicylate poisoning" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "253" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Intoxicación por salicilatos" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Carlos Ruiz-Zorrilla López, Belén Gómez-Giralda, Antonio Molina-Miguel" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Carlos" "apellidos" => "Ruiz-Zorrilla López" ] 1 => array:2 [ "nombre" => "Belén" "apellidos" => "Gómez-Giralda" ] 2 => array:2 [ "nombre" => "Antonio" "apellidos" => "Molina-Miguel" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X021169951200077X" "doi" => "10.3265/Nefrologia.pre2012.Jan.11343" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169951200077X?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412000777?idApp=UINPBA000064" "url" => "/20132514/0000003200000002/v0_201502091616/X2013251412000777/v0_201502091617/en/main.assets" ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Use of estimated glomerular filtration formulas for dose adjustment" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "253" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Rosario Montañés-Bermúdez, Sílvia Gràcia-Garcia" "autores" => array:2 [ 0 => array:4 [ "nombre" => "Rosario" "apellidos" => "Montañés-Bermúdez" "email" => array:1 [ 0 => "rmontanes@fundacio-puigvert.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 1 => array:3 [ "nombre" => "Sílvia" "apellidos" => "Gràcia-Garcia" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:3 [ "entidad" => "Servicio de Laboratorio, Fundació Puigvert, Barcelona, " "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Utilización de las ecuaciones de estimación del filtrado glomerular para el ajuste de dosis de fármacos" ] ] "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">To the Editor,</span></p><p class="elsevierStylePara">While we agree with many of the ideas expressed in the letter by Peral et al,<span class="elsevierStyleSup">1</span> we would like to expand on the following:</p><p class="elsevierStylePara">1. Clinical laboratories in Spain, according to national recommendations,<span class="elsevierStyleSup">2</span> generate analytical reports including the glomerular filtration rate (GFR) calculated by means of an equation. Unpublished data from a national survey carried out by the Kidney Function Commission of the Spanish Society of Clinical Biochemistry and Molecular Pathology (CFR-SEQC), show that out of 281 laboratories surveyed, 88% report GFR. Of these reporting laboratories, 32% calculate GFR using the MDRD-IDMS equation, 62% use the MDRD-4 equation and 4% use the Cockcroft-Gault (CG) or Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formulas. Standard procedures for measuring creatinine have become increasingly available in Spain, but it is true that some laboratories that introduced GFR calculated by MDRD-4 (factor 186) in past years have not yet made the necessary leap to the MDRD-IDMS method (factor 175). The CFR-SEQC is undertaking a series of actions in order to correct this situation.</p><p class="elsevierStylePara">2. We are grateful that the error in the description of the CKD-EPI equation in our article in <span class="elsevierStyleItalic">Nefrología</span><span class="elsevierStyleSup">3</span> was reported. With a view to correcting this and other errors, we sent a list of errata to the journal.</p><p class="elsevierStylePara">3. The recommendations by pharmaceutical companies with regard to adjusting drug doses in patients with compromised renal function follow the Food and Drug Administration (FDA) guidelines and are based on creatinine clearance intervals obtained by using the CG equation.<span class="elsevierStyleSup">4</span> However, neither the methods for measuring creatinine nor the patient samples used to develop the equation are available, meaning that the equation cannot be reformulated for use with creatinine values obtained using current methods. Creatinine clearance values obtained using the CG equation are 10%-20% higher if standard procedures are followed, which overestimates renal function and therefore affects drug dose adjustments.</p><p class="elsevierStylePara">GFR values obtained by using the CG and MDRD methods are not interchangeable. Different studies that compare dosage adjustments based on the CG and MDRD methods report differences in between 10% and 40% of cases.<span class="elsevierStyleSup">5</span> Comparing these studies is difficult due to the variability of the creatinine measurement methods used when calculating the equations and the type of patients studied. In addition, their interpretation is complex, since they do not assess the clinical consequences of discrepancies between doses that result from using one equation or another. Only one study compares concordance between the assignment to an FDA-listed category, based on GFR measurement (iothalamate clearance), and 3 equations (MDRD-IDMS, CG using real weight, and CG using the ideal weight value), in addition to differences in recommended doses between the 3 equations with respect to 15 drugs that are excreted renally.<span class="elsevierStyleSup">6</span> Results from the comparison show that concordance with the recommended doses of the 15 drugs, based on the GFR measurement, was greater for MDRD-IDMS (88%) than for CG with ideal weight (82%) or CG with real weight (85%). Concordance between recommended doses was 89% between MDRD-IDMS and CG with ideal weight.</p><p class="elsevierStylePara">The American College of Clinical Pharmacy Nephrology Practice and Research Network recommends that neither CG nor MDRD be used as the only measurement to determine dosage-adjustment decisions. Other factors should also be considered, such as the way equations work in specific population groups, the therapeutic index, drug indication and toxicity profile, availability of other treatment agents, the possibility of monitoring drug concentrations in blood and more precise means of measuring creatinine clearance or glomerular filtration rate.<span class="elsevierStyleSup">5</span> The National Kidney Foundation Education Program recommends that both CG and MDRD-IDMS be used when estimating renal function in order to adjust drug doses.<span class="elsevierStyleSup">7</span> Likewise, the FDA recently proposed that MDRD-IDMS be used along with CG in future pharmacokinetic studies in patients with kidney disease.<span class="elsevierStyleSup">8</span></p><p class="elsevierStylePara">We believe that the value of GFR calculated based on the MDRD-IDMS equation is a valid tool for assessing renal function for purposes of adjusting drug doses for several reasons: 1) it is based on creatinine measurement procedures that have been standardised against the reference method; 2) it correlates better with measured GFR than the CG method for GFR values <60ml/min/1.73m<span class="elsevierStyleSup">2</span>, which are the most susceptible to dosage adjustments; and 3) it is available in most clinical laboratory reports, unlike CG.</p><p class="elsevierStylePara">We agree with Peral et al that while the GFR value obtained by MDRD-IDMS is expressed in ml/min/1.73m<span class="elsevierStyleSup">2</span>, absolute values (ml/min) should be used for this purpose in patients whose body surface area varies considerably from the standard area of 1.73m<span class="elsevierStyleSup">2</span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara"><span class="elsevierStyleBold">Conflicts of interest</span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara">The authors affirm that they have no conflicts of interest related to the content of this article.</p>" "pdfFichero" => "P1-E534-S3461-A11339-EN.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:8 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Peral J, Lertxundi U, Saracho R, Iturrizaga S, Martínez MJ. Estimación de la tasa de filtración glomerular para el ajuste posológico de los fármacos. Reina la confusión. Nefrologia 2010;32(1):115-7." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Gracia S, Montañés R, Bover J, Cases A, Deulofeu R, Martín de Francisco AL, et al. Recomendaciones sobre la utilización de ecuaciones de estimación del filtrado glomerular en adultos. Documento de consenso de la Sociedad Española de Bioquímica Clínica y Patología Molecular y Sociedad Española de Nefrología. Nefrologia 2006;26(6):658-65. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17227242" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Montañés R, Bover J, Oliver A, Ballarín JA, Gracia S. Valoración de la nueva ecuación CKD-EPI para la estimación del filtrado glomerular. Nefrologia 2010;30(2):185-94. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20038962" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "U.S. Food and Drug Administration. Guidance for industry: pharmacokinetics in patients with impaired renal function ¿ study design, data analysis, and impact on dosing and labeling. May 1998.\u{A0}Available at:\u{A0}http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072127.pdf. [Accessed: January 10, 2012]." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "\u{A0}5. Nyman HA, Dowling TC, Hudson JQ, Peter WL, Joy MS, Nolin TD. Comparative evaluation of the Cockcroft-Gault Equation and the Modification of Diet in Renal Disease (MDRD) study equation for drug dosing: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy 2011;31(11):1130-44." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "\u{A0}6. Stevens LA, Nolin TD, Richardson MM,\u{A0}Feldman HI, Lewis JB, Rodby R, et al.\u{A0} Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis 2009;54(1):33-42. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19446939" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "National Kidney Disease Education Program (NKDEP). Estimation of Kidney Function for Prescription Medication Dosage in Adults. Available at: http://nkdep.nih.gov/professionals/drug-dosing-information.htm. [Updated: January 27, 2011. Accessed: January 10, 2012]." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "U.S. Food and Drug Administration. Guidance for industry: pharmacokinetics in patients with impaired renal function ¿ study design, data analysis, and impact on dosing and labeling. Draft guidance. March 2010. Available at:\u{A0}http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM204959.pdf. [Accessed: January 10, 2012]." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000003200000002/v0_201502091616/X2013251412000769/v0_201502091617/en/main.assets" "Apartado" => array:4 [ "identificador" => "35439" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor - Comments on published articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003200000002/v0_201502091616/X2013251412000769/v0_201502091617/en/P1-E534-S3461-A11339-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412000769?idApp=UINPBA000064" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 3 | 11 | 14 |
2024 October | 56 | 33 | 89 |
2024 September | 66 | 27 | 93 |
2024 August | 83 | 59 | 142 |
2024 July | 34 | 32 | 66 |
2024 June | 45 | 33 | 78 |
2024 May | 70 | 26 | 96 |
2024 April | 38 | 36 | 74 |
2024 March | 40 | 23 | 63 |
2024 February | 49 | 38 | 87 |
2024 January | 41 | 30 | 71 |
2023 December | 19 | 27 | 46 |
2023 November | 32 | 39 | 71 |
2023 October | 43 | 46 | 89 |
2023 September | 27 | 33 | 60 |
2023 August | 19 | 12 | 31 |
2023 July | 32 | 35 | 67 |
2023 June | 29 | 27 | 56 |
2023 May | 29 | 32 | 61 |
2023 April | 23 | 17 | 40 |
2023 March | 34 | 26 | 60 |
2023 February | 19 | 19 | 38 |
2023 January | 28 | 23 | 51 |
2022 December | 38 | 30 | 68 |
2022 November | 26 | 26 | 52 |
2022 October | 28 | 42 | 70 |
2022 September | 44 | 28 | 72 |
2022 August | 39 | 47 | 86 |
2022 July | 35 | 44 | 79 |
2022 June | 32 | 26 | 58 |
2022 May | 36 | 26 | 62 |
2022 April | 36 | 54 | 90 |
2022 March | 42 | 66 | 108 |
2022 February | 80 | 40 | 120 |
2022 January | 71 | 32 | 103 |
2021 December | 58 | 39 | 97 |
2021 November | 65 | 54 | 119 |
2021 October | 52 | 31 | 83 |
2021 September | 53 | 42 | 95 |
2021 August | 70 | 41 | 111 |
2021 July | 61 | 33 | 94 |
2021 June | 45 | 25 | 70 |
2021 May | 54 | 37 | 91 |
2021 April | 100 | 86 | 186 |
2021 March | 102 | 39 | 141 |
2021 February | 76 | 18 | 94 |
2021 January | 33 | 15 | 48 |
2020 December | 47 | 20 | 67 |
2020 November | 57 | 9 | 66 |
2020 October | 30 | 22 | 52 |
2020 September | 36 | 3 | 39 |
2020 August | 33 | 13 | 46 |
2020 July | 43 | 9 | 52 |
2020 June | 38 | 10 | 48 |
2020 May | 31 | 8 | 39 |
2020 April | 32 | 16 | 48 |
2020 March | 35 | 12 | 47 |
2020 February | 58 | 22 | 80 |
2020 January | 72 | 24 | 96 |
2019 December | 59 | 16 | 75 |
2019 November | 52 | 21 | 73 |
2019 October | 46 | 11 | 57 |
2019 September | 48 | 30 | 78 |
2019 August | 24 | 13 | 37 |
2019 July | 31 | 20 | 51 |
2019 June | 25 | 15 | 40 |
2019 May | 37 | 16 | 53 |
2019 April | 38 | 28 | 66 |
2019 March | 28 | 17 | 45 |
2019 February | 19 | 19 | 38 |
2019 January | 37 | 15 | 52 |
2018 December | 66 | 46 | 112 |
2018 November | 90 | 18 | 108 |
2018 October | 83 | 11 | 94 |
2018 September | 66 | 16 | 82 |
2018 August | 51 | 15 | 66 |
2018 July | 45 | 16 | 61 |
2018 June | 45 | 13 | 58 |
2018 May | 42 | 13 | 55 |
2018 April | 49 | 10 | 59 |
2018 March | 48 | 16 | 64 |
2018 February | 48 | 12 | 60 |
2018 January | 43 | 8 | 51 |
2017 December | 50 | 11 | 61 |
2017 November | 41 | 5 | 46 |
2017 October | 35 | 10 | 45 |
2017 September | 43 | 11 | 54 |
2017 August | 32 | 13 | 45 |
2017 July | 38 | 13 | 51 |
2017 June | 32 | 9 | 41 |
2017 May | 47 | 13 | 60 |
2017 April | 33 | 5 | 38 |
2017 March | 35 | 18 | 53 |
2017 February | 28 | 14 | 42 |
2017 January | 32 | 16 | 48 |
2016 December | 79 | 8 | 87 |
2016 November | 114 | 12 | 126 |
2016 October | 142 | 16 | 158 |
2016 September | 158 | 7 | 165 |
2016 August | 270 | 6 | 276 |
2016 July | 220 | 11 | 231 |
2016 June | 163 | 0 | 163 |
2016 May | 140 | 0 | 140 |
2016 April | 120 | 0 | 120 |
2016 March | 79 | 0 | 79 |
2016 February | 99 | 0 | 99 |
2016 January | 103 | 0 | 103 |
2015 December | 137 | 0 | 137 |
2015 November | 93 | 0 | 93 |
2015 October | 76 | 0 | 76 |
2015 September | 114 | 0 | 114 |
2015 August | 69 | 0 | 69 |
2015 July | 72 | 0 | 72 |
2015 June | 36 | 0 | 36 |
2015 May | 62 | 0 | 62 |
2015 April | 9 | 0 | 9 |